The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The intestinal epithelium and underlying lamina propria contain T cells that play important roles in maintaining colonic homeostasis. These T cells mediate substantial and specific regulation to ensure that pathogenic microorganisms are eliminated while commensal bacteria are tolerated. There is considerable evidence supporting the notion that the altered ratio between Foxp3+CD4+ T regulatory cells and T effector cells in the colonic microenvironment might contribute to the initiation and progression of inflammation and eventually development of colon cancer. Recent findings on the heterogeneity and plasticity of T regulatory cells, such as the identification of IL-17+Foxp3+CD4+ and the RORγt+Foxp3+CD4+ subsets, in patients with colorectal inflammation and cancer have provided a new twist in our understanding of the pathogenesis of colonic diseases. Phenotypic and functional properties of IL-17-producing Foxp3+CD4+ T cells as well as the significant implications of these cells in the initiation and progression of colorectal diseases are discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1×
“Studies have shown that commensal bacteria can direct the development of Foxp3+ TReg cells with a unique ‘inducible” genetic signature, suggesting the existence of a mechanism via which microbiota can actively promote mucosal tolerance by inducing the differentiation of conventional T cells into Foxp3+ TReg cells [36].”
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
A peripheral circulating compartment of natural naive CD4 Tregs
Valmori, D., Merlo, A., Souleimanian, N. E., Hesdorffer, C. S., & Ayyoub, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23963 · Cited by 319 · cited 1×
“CD45RA+Foxp3+ naïve TReg cells, are present in peripheral blood and prevalent in cord blood [16,17] and are considered the human counterparts of mouse natural TReg cells that develop in the thymus.”
Persistence of naive CD45RA+ regulatory T cells in adult life
Seddiki, N., Santner-Nanan, B., Tangye, S. G., Alexander, S. I., Solomon, M., Lee, S., Nanan, R., & de Saint Groth, B. F. (2006) · Blood · doi:10.1182/blood-2005-06-2403 · Cited by 284
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214 · cited 1×
“These findings might provide an explanation why TH17 cells are often detected alongside TReg cells within tumor tissues or systemically in cancer patients [7,55,56] and further suggest that the TReg population might be an appropriate target for cancer immunotherapy.”
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice
Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211 · cited 1×
“However, studies using ApcMin/+ mice revealed a protective role of IL-10-producing TReg cells in bacterial-induced chronic inflammation and cancer [47] and even hereditary colon cancer [48], suggesting that TReg cells might play a protective role in cancer by suppressing inflammation (Fig.”
Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-65 · Cited by 154
Cited by
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 789
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Romano, M., Fanelli, G., Albany, C. J., Giganti, G., & Lombardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00043 · Cited by 512
“Whereas, Th17-like Tregs are increased in psoriasis (49) patients and inflammatory bowel diseases (50, 51) with no loss of function.”
BackgroundImmunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 355
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
Wu, W., Sun, M., Zhang, H.-P., Chen, T., Wu, R., Liu, C., Yang, G., Geng, X.-R., Feng, B.-S., Liu, Z., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306083 · Cited by 93
Single-cell RNA-seq unveils critical regulators of human FOXP3+ regulatory T cell stability
Yi, G., Zhao, Y., Xie, F., Zhu, F., Wan, Z., Wang, J., Wang, X., Gao, K., Cao, L., Li, X., et al. (2020) · Science Bulletin · doi:10.1016/j.scib.2020.01.002 · Cited by 27
Metadata
- Authors
- Li, L., & Boussiotis, V. A.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 148
- Issue
- 2
- Pages
- 246-253
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2011415977
- Cited by
- 75
- References
- 10
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.